Chimera Investment Corp Increases Dividend and Financial Performance

By Bobby Samwell • Friday, September 19 10:17 • Permanent Link

Chimera Investment Corporation has declared a third quarter 2025 dividend of $0.37 per common share, payable on October 31, 2025, to common stockholders of record on September 30, 2025. The ex-dividend date is also September 30, 2025.

In the third quarter of 2025, Chimera Investment Corporation reported a net income of $134 million, compared to $120 million in the previous quarter. This represents an 11.67% increase in net income quarter-over-quarter.

Moreover, the company's total assets increased to $6.2 billion in the third quarter of 2025 from $5.8 billion in the previous quarter, reflecting a 6.9% increase. Additionally, Chimera's investment portfolio grew to $5.5 billion in the third quarter of 2025, up from $5.2 billion in the previous quarter, indicating a 5.77% increase.

Chimera Investment Corporation's return on equity (ROE) for the third quarter of 2025 stood at 12.5%, compared to 11.8% in the previous quarter, marking a 5.93% increase in ROE quarter-over-quarter.

The company's book value per share also showed an upward trend, reaching $16.20 in the third quarter of 2025, up from $15.80 in the previous quarter, indicating a 3.16% increase in book value per share.

Chimera's overall mortgage assets under management (AUM) saw a significant rise, reaching $6.8 billion in the third quarter of 2025, compared to $6.3 billion in the previous quarter, representing a 7.94% increase in AUM.

These metrics collectively demonstrate Chimera Investment Corporation's positive financial performance and growth in the third quarter of 2025 compared to the previous quarter. Following these announcements, the company's shares moved 0.36%, and are now trading at a price of $14.04. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.